Statement from FDA Commissioner Scott Gottlieb, M.D., on the agency’s efforts to improve drug quality through vigilant oversight of data integrity and good manufacturing practice - FDA Press Releases

FDA releases guidance with recommendations for drug manufacturers regarding good manufacturing practices and data integrity

from Food and Drug Administration--Press Releases https://ift.tt/2ROtOzu
via IFTTT